PL369675A1 - Zastosowanie pochodnych N-(indolokarbonylo)piperazyny - Google Patents
Zastosowanie pochodnych N-(indolokarbonylo)piperazynyInfo
- Publication number
- PL369675A1 PL369675A1 PL02369675A PL36967502A PL369675A1 PL 369675 A1 PL369675 A1 PL 369675A1 PL 02369675 A PL02369675 A PL 02369675A PL 36967502 A PL36967502 A PL 36967502A PL 369675 A1 PL369675 A1 PL 369675A1
- Authority
- PL
- Poland
- Prior art keywords
- indolcarbonyl
- piperazine derivatives
- piperazine
- derivatives
- Prior art date
Links
- 150000004885 piperazines Chemical class 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10157673A DE10157673A1 (de) | 2001-11-24 | 2001-11-24 | Verwendung von N-(Indolcarbonyl-)piperazinderivaten |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL369675A1 true PL369675A1 (pl) | 2005-05-02 |
| PL207565B1 PL207565B1 (pl) | 2011-01-31 |
Family
ID=7706831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL369675A PL207565B1 (pl) | 2001-11-24 | 2002-10-28 | Zastosowanie pochodnych N-(indolokarbonylo)piperazyny |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20050014766A1 (pl) |
| EP (1) | EP1448201B1 (pl) |
| JP (1) | JP2005511640A (pl) |
| KR (1) | KR100953172B1 (pl) |
| CN (1) | CN1319532C (pl) |
| AR (1) | AR037404A1 (pl) |
| AU (1) | AU2002349012B2 (pl) |
| BR (1) | BR0214347A (pl) |
| CA (1) | CA2468380A1 (pl) |
| DE (2) | DE10157673A1 (pl) |
| ES (1) | ES2297018T3 (pl) |
| HU (1) | HUP0402388A3 (pl) |
| IL (2) | IL162125A0 (pl) |
| MX (1) | MXPA04004766A (pl) |
| MY (1) | MY141210A (pl) |
| NZ (1) | NZ533667A (pl) |
| PE (1) | PE20030710A1 (pl) |
| PL (1) | PL207565B1 (pl) |
| RU (1) | RU2317083C2 (pl) |
| UA (1) | UA77468C2 (pl) |
| WO (1) | WO2003045392A2 (pl) |
| ZA (1) | ZA200404967B (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10246357A1 (de) * | 2002-10-04 | 2004-04-15 | Merck Patent Gmbh | Verwendung von 5-HT2Rezeptorantagonisten |
| DE102004047517A1 (de) * | 2004-09-28 | 2006-03-30 | Merck Patent Gmbh | Neuartige Kristallform von (3-Cyan-1H-indol-7-yl)-[4-(4-fluorphenethyl)-piperazin-1-yl]-methanon, Hydrochlorid |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0168003B1 (en) * | 1984-07-06 | 1991-04-03 | Otsuka Pharmaceutical Co., Ltd. | Oxindol compounds, compositions containing same and processes for preparing same |
| HUT69705A (en) * | 1991-11-25 | 1995-09-28 | Pfizer | Indole derivatives |
| GB9718712D0 (en) * | 1997-09-03 | 1997-11-12 | Merck Sharp & Dohme | Theraputic Agents |
| BR9910583A (pt) * | 1998-04-29 | 2001-01-09 | Ortho Mcneil Pharm Inc | Aminotetralinas n-substituìdas como ligantes para o receptor de neuropeptìdeo y y5 úteis no tratamento de obesidade e outros distúrbios |
| GB9825413D0 (en) * | 1998-11-19 | 1999-01-13 | Lilly Co Eli | Pharmaceutical compounds |
| DE19934433A1 (de) * | 1999-07-22 | 2001-01-25 | Merck Patent Gmbh | N-(Indolcarbonyl-)piperazinderivate |
| DE19934432A1 (de) * | 1999-07-22 | 2001-02-01 | Merck Patent Gmbh | Indolderivate |
| CA2379585C (en) * | 1999-09-30 | 2006-06-20 | James W. Darrow | Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines |
-
2001
- 2001-11-24 DE DE10157673A patent/DE10157673A1/de not_active Withdrawn
-
2002
- 2002-10-28 EP EP02781293A patent/EP1448201B1/de not_active Expired - Lifetime
- 2002-10-28 KR KR1020047006419A patent/KR100953172B1/ko not_active Expired - Fee Related
- 2002-10-28 UA UA20040604937A patent/UA77468C2/uk unknown
- 2002-10-28 WO PCT/EP2002/012009 patent/WO2003045392A2/de not_active Ceased
- 2002-10-28 CN CNB028230620A patent/CN1319532C/zh not_active Expired - Fee Related
- 2002-10-28 ES ES02781293T patent/ES2297018T3/es not_active Expired - Lifetime
- 2002-10-28 NZ NZ533667A patent/NZ533667A/en not_active IP Right Cessation
- 2002-10-28 PL PL369675A patent/PL207565B1/pl not_active IP Right Cessation
- 2002-10-28 JP JP2003546894A patent/JP2005511640A/ja active Pending
- 2002-10-28 AU AU2002349012A patent/AU2002349012B2/en not_active Ceased
- 2002-10-28 CA CA002468380A patent/CA2468380A1/en not_active Abandoned
- 2002-10-28 MX MXPA04004766A patent/MXPA04004766A/es active IP Right Grant
- 2002-10-28 RU RU2004119303/15A patent/RU2317083C2/ru not_active IP Right Cessation
- 2002-10-28 US US10/496,572 patent/US20050014766A1/en not_active Abandoned
- 2002-10-28 HU HU0402388A patent/HUP0402388A3/hu unknown
- 2002-10-28 IL IL16212502A patent/IL162125A0/xx unknown
- 2002-10-28 DE DE50211298T patent/DE50211298D1/de not_active Expired - Lifetime
- 2002-10-28 BR BR0214347-0A patent/BR0214347A/pt not_active IP Right Cessation
- 2002-11-20 PE PE2002001114A patent/PE20030710A1/es not_active Application Discontinuation
- 2002-11-20 MY MYPI20024337A patent/MY141210A/en unknown
- 2002-11-22 AR ARP020104495A patent/AR037404A1/es unknown
-
2004
- 2004-05-23 IL IL162125A patent/IL162125A/en not_active IP Right Cessation
- 2004-06-23 ZA ZA200404967A patent/ZA200404967B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1448201B1 (de) | 2007-11-28 |
| UA77468C2 (en) | 2006-12-15 |
| AR037404A1 (es) | 2004-11-10 |
| PE20030710A1 (es) | 2003-08-21 |
| MXPA04004766A (es) | 2004-07-30 |
| RU2004119303A (ru) | 2005-04-20 |
| KR20040072624A (ko) | 2004-08-18 |
| WO2003045392A2 (de) | 2003-06-05 |
| NZ533667A (en) | 2006-11-30 |
| WO2003045392A8 (de) | 2004-12-29 |
| HUP0402388A2 (hu) | 2005-03-29 |
| EP1448201A2 (de) | 2004-08-25 |
| WO2003045392A3 (de) | 2003-09-18 |
| HK1073243A1 (en) | 2005-09-30 |
| CN1589147A (zh) | 2005-03-02 |
| JP2005511640A (ja) | 2005-04-28 |
| BR0214347A (pt) | 2004-10-26 |
| CN1319532C (zh) | 2007-06-06 |
| AU2002349012B2 (en) | 2008-01-24 |
| US20050014766A1 (en) | 2005-01-20 |
| KR100953172B1 (ko) | 2010-04-20 |
| IL162125A0 (en) | 2005-11-20 |
| IL162125A (en) | 2010-12-30 |
| PL207565B1 (pl) | 2011-01-31 |
| ZA200404967B (en) | 2005-08-05 |
| DE10157673A1 (de) | 2003-06-05 |
| RU2317083C2 (ru) | 2008-02-20 |
| MY141210A (en) | 2010-03-31 |
| AU2002349012A1 (en) | 2003-06-10 |
| CA2468380A1 (en) | 2003-06-05 |
| DE50211298D1 (de) | 2008-01-10 |
| ES2297018T3 (es) | 2008-05-01 |
| HUP0402388A3 (en) | 2009-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL157659A0 (en) | New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
| IL156737A0 (en) | Substituted amine derivatives and methods of use | |
| PT1438306E (pt) | Derivados de uk-20 | |
| IL161258A0 (en) | Heterocyclic compounds and methods of use | |
| DK1198453T3 (da) | N-(indolcarbonyl-)piperazinderivater | |
| IL151923A0 (en) | Novel piperazine derivatives | |
| PL377861A1 (pl) | Podstawione pochodne aminowe oraz sposoby wykorzystania | |
| GB0013378D0 (en) | Use of therapeutic benzamide derivatives | |
| HUP0402025A3 (en) | Novel bensophenone derivatives or salts thereof and their use | |
| PL369076A1 (pl) | Pochodne piperazyny | |
| GB0013383D0 (en) | Therapeutic benzamide derivatives | |
| GB0106177D0 (en) | Piperazine derivatives | |
| GB0013346D0 (en) | Therapeutic benzamide derivatives | |
| PL367676A1 (pl) | Nowe pochodne heterocykliczne i ich zastosowanie w medycynie | |
| HUP0500734A3 (en) | Use of 2-alkoxyphenyl-substituted imidazotriazinones | |
| HUP0401641A3 (en) | Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors | |
| PL367639A1 (pl) | Nowy związek heterocykliczny i jego zastosowanie w medycynie | |
| IL150862A0 (en) | Heterocyclic amide derivatives | |
| IL162125A0 (en) | Use of n-(indolcarbonyl-) piperazine derivatives | |
| IL161521A0 (en) | N-formyl derivatives of paroxetine | |
| GB0109287D0 (en) | Therapeutic benzamide derivatives | |
| HUP0203929D0 (en) | New use of substituted alkyl-piridazinone derivatives | |
| ZA200305198B (en) | Substituted amine derivatives and methods of use. | |
| GB0109520D0 (en) | Use of (di-substituted-phenyl)-pyrimidinyl-imidazole derivatives as njk-inhibitors | |
| AU2002238356A1 (en) | New use of phencynonate hydrochloride |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Decisions on the lapse of the protection rights |
Effective date: 20111028 |